| ■ 영문 제목 : Global Platinum based Cancer Drug Market Growth 2021-2026 | |
 | ■ 상품코드 : LPI-2201K02153 ■ 조사/발행회사 : LP Information ■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.) ■ 페이지수 : 105 ■ 작성언어 : 영어 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의약품 |
| Single User (1명 열람용) | USD3,660 ⇒환산￦5,124,000 | 견적의뢰/주문/질문 |
| Multi User (5명 열람용) | USD5,490 ⇒환산￦7,686,000 | 견적의뢰/주문/질문 |
| Corporate User (동일기업내 공유가능) | USD7,320 ⇒환산￦10,248,000 | 견적의뢰/구입/질문 |
|
※가격옵션 설명 - 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다. - 지불방법은 계좌이체/무통장입금 또는 카드결제입니다. |
| 본 조사보고서는 백금 기반 암 치료제의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (시스플라틴, 옥살리플라틴, 카보플라틴, 기타)와 용도별 시장규모 (결장 직장암, 난소암, 폐암, 기타) 데이터도 수록되어 있습니다. - 조사 범위 - 경영자용 요약 - 기업별 백금 기반 암 치료제 시장 점유율 - 지역별 백금 기반 암 치료제 시장규모 - 주요지역의 종류별 시장규모 (시스플라틴, 옥살리플라틴, 카보플라틴, 기타) - 주요지역의 용도별 시장규모 (결장 직장암, 난소암, 폐암, 기타) - 미주의 백금 기반 암 치료제 시장규모 (미국, 캐나다, 멕시코, 브라질 등) - 아시아의 백금 기반 암 치료제 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등) - 유럽의 백금 기반 암 치료제 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등) - 중동/아프리카의 백금 기반 암 치료제 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등) - 시장의 성장요인, 과제, 동향 - 마케팅, 유통업자, 고객리스트 - 세계의 백금 기반 암 치료제 시장예측 (2021년-2026년) - 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical, Teva, Pfizer, Dr Reddy's Laboratories, Mylan, Sun Pharma, Novartis, Debiopharm, Accord Healthcare, SK Chemicals - 조사의 결과/결론 |
According to this latest study, the 2021 growth of Platinum based Cancer Drug will have significant change from previous year. By the most conservative estimates of global Platinum based Cancer Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 1451 million in 2020. Over the next five years the Platinum based Cancer Drug market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 1620.5 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Platinum based Cancer Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Cisplatin
Oxaliplatin
Carboplatin
Others
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy’s Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
1 Scope of the Report 2 Executive Summary 3 Global Platinum based Cancer Drug by Company 4 Platinum based Cancer Drug by Region 5 Americas 6 APAC 7 Europe 8 Middle East & Africa 9 Market Drivers, Challenges and Trends 10 Marketing, Distributors and Customer 11 Global Platinum based Cancer Drug Market Forecast 12 Key Players Analysis 13 Research Findings and Conclusion List of TablesTable 1. Platinum based Cancer Drug Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Cisplatin Table 3. Major Players of Oxaliplatin Table 4. Major Players of Carboplatin Table 5. Major Players of Others Table 6. Global Platinum based Cancer Drug Sales by Type (2016-2021) & (K Units) Table 7. Global Platinum based Cancer Drug Sales Market Share by Type (2016-2021) Table 8. Global Platinum based Cancer Drug Revenue by Type (2016-2021) & ($ million) Table 9. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2021) Table 10. Global Platinum based Cancer Drug Sale Price by Type (2016-2021) Table 11. Global Platinum based Cancer Drug Sales by Application (2016-2021) & (K Units) Table 12. Global Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Table 13. Global Platinum based Cancer Drug Value by Application (2016-2021) Table 14. Global Platinum based Cancer Drug Revenue Market Share by Application (2016-2021) Table 15. Global Platinum based Cancer Drug Sale Price by Application (2016-2021) Table 16. Global Platinum based Cancer Drug Sales by Company (2019-2021) & (K Units) Table 17. Global Platinum based Cancer Drug Sales Market Share by Company (2019-2021) Table 18. Global Platinum based Cancer Drug Revenue by Company (2019-2021) ($ Millions) Table 19. Global Platinum based Cancer Drug Revenue Market Share by Company (2019-2021) Table 20. Global Platinum based Cancer Drug Sale Price by Company (2019-2021) Table 21. Key Manufacturers Platinum based Cancer Drug Producing Area Distribution and Sales Area Table 22. Players Platinum based Cancer Drug Products Offered Table 23. Platinum based Cancer Drug Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Platinum based Cancer Drug Sales by Region (2016-2021) (K Units) Table 27. Global Platinum based Cancer Drug Sales Market Share by Region (2016-2021) Table 28. Global Platinum based Cancer Drug Revenue by Region (2016-2021) & ($ Millions) Table 29. Global Platinum based Cancer Drug Revenue Market Share by Region (2016-2021) Table 30. Americas Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units) Table 31. Americas Platinum based Cancer Drug Sales Market Share by Country (2016-2021) Table 32. Americas Platinum based Cancer Drug Revenue by Country (2016-2021) & ($ Millions) Table 33. Americas Platinum based Cancer Drug Revenue Market Share by Country (2016-2021) Table 34. Americas Platinum based Cancer Drug Sales by Type (2016-2021) & (K Units) Table 35. Americas Platinum based Cancer Drug Sales Market Share by Type (2016-2021) Table 36. Americas Platinum based Cancer Drug Sales by Application (2016-2021) & (K Units) Table 37. Americas Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Table 38. APAC Platinum based Cancer Drug Sales by Region (2016-2021) & (K Units) Table 39. APAC Platinum based Cancer Drug Sales Market Share by Region (2016-2021) Table 40. APAC Platinum based Cancer Drug Revenue by Region (2016-2021) & ($ Millions) Table 41. APAC Platinum based Cancer Drug Revenue Market Share by Region (2016-2021) Table 42. APAC Platinum based Cancer Drug Sales by Type (2016-2021) & (K Units) Table 43. APAC Platinum based Cancer Drug Sales Market Share by Type (2016-2021) Table 44. APAC Platinum based Cancer Drug Sales by Application (2016-2021) & (K Units) Table 45. APAC Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Table 46. Europe Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units) Table 47. Europe Platinum based Cancer Drug Sales Market Share by Country (2016-2021) Table 48. Europe Platinum based Cancer Drug Revenue by Country (2016-2021) & ($ Millions) Table 49. Europe Platinum based Cancer Drug Revenue Market Share by Country (2016-2021) Table 50. Europe Platinum based Cancer Drug Sales by Type (2016-2021) & (K Units) Table 51. Europe Platinum based Cancer Drug Sales Market Share by Type (2016-2021) Table 52. Europe Platinum based Cancer Drug Sales by Application (2016-2021) & (K Units) Table 53. Europe Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Table 54. Middle East & Africa Platinum based Cancer Drug Sales by Country (2016-2021) & (K Units) Table 55. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Country (2016-2021) Table 56. Middle East & Africa Platinum based Cancer Drug Revenue by Country (2016-2021) & ($ Millions) Table 57. Middle East & Africa Platinum based Cancer Drug Revenue Market Share by Country (2016-2021) Table 58. Middle East & Africa Platinum based Cancer Drug Sales by Type (2016-2021) & (K Units) Table 59. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Type (2016-2021) Table 60. Middle East & Africa Platinum based Cancer Drug Sales by Application (2016-2021) & (K Units) Table 61. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Table 62. Key and Potential Regions of Platinum based Cancer Drug Table 63. Key Application and Potential Industries of Platinum based Cancer Drug Table 64. Key Challenges of Platinum based Cancer Drug Table 65. Key Trends of Platinum based Cancer Drug Table 66. Platinum based Cancer Drug Distributors List Table 67. Platinum based Cancer Drug Customer List Table 68. Global Platinum based Cancer Drug Sales Forecast by Region (2021-2026) & (K Units) Table 69. Global Platinum based Cancer Drug Consumption Market Forecast by Region Table 70. Global Platinum based Cancer Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 71. Global Platinum based Cancer Drug Revenue Market Share Forecast by Region (2021-2026) Table 72. Americas Platinum based Cancer Drug Sales Forecast by Country (2021-2026) & (K Units) Table 73. Americas Platinum based Cancer Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 74. APAC Platinum based Cancer Drug Sales Forecast by Region (2021-2026) & (K Units) Table 75. APAC Platinum based Cancer Drug Revenue Forecast by Region (2021-2026) & ($ millions) Table 76. Europe Platinum based Cancer Drug Sales Forecast by Country (2021-2026) & (K Units) Table 77. Europe Platinum based Cancer Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Middle East & Africa Platinum based Cancer Drug Sales Forecast by Country (2021-2026) & (K Units) Table 79. Middle East & Africa Platinum based Cancer Drug Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. Global Platinum based Cancer Drug Sales Forecast by Type (2021-2026) & (K Units) Table 81. Global Platinum based Cancer Drug Sales Market Share Forecast by Type (2021-2026) Table 82. Global Platinum based Cancer Drug Revenue Forecast by Type (2021-2026) & ($ Millions) Table 83. Global Platinum based Cancer Drug Revenue Market Share Forecast by Type (2021-2026) Table 84. Global Platinum based Cancer Drug Sales Forecast by Application (2021-2026) & (K Units) Table 85. Global Platinum based Cancer Drug Sales Market Share Forecast by Application (2021-2026) Table 86. Global Platinum based Cancer Drug Revenue Forecast by Application (2021-2026) & ($ Millions) Table 87. Global Platinum based Cancer Drug Revenue Market Share Forecast by Application (2021-2026) Table 88. Sanofi Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 89. Sanofi Platinum based Cancer Drug Product Offered Table 90. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 91. Sanofi Main Business Table 92. Sanofi Latest Developments Table 93. Hengrui Medicine Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 94. Hengrui Medicine Platinum based Cancer Drug Product Offered Table 95. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 96. Hengrui Medicine Main Business Table 97. Hengrui Medicine Latest Developments Table 98. ASK Pharma Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 99. ASK Pharma Platinum based Cancer Drug Product Offered Table 100. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 101. ASK Pharma Main Business Table 102. ASK Pharma Latest Developments Table 103. Yi Bai Pharmaceutical Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 104. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Offered Table 105. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 106. Yi Bai Pharmaceutical Main Business Table 107. Yi Bai Pharmaceutical Latest Developments Table 108. Qilu Pharmaceutical Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 109. Qilu Pharmaceutical Platinum based Cancer Drug Product Offered Table 110. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 111. Qilu Pharmaceutical Main Business Table 112. Qilu Pharmaceutical Latest Developments Table 113. Teva Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 114. Teva Platinum based Cancer Drug Product Offered Table 115. Teva Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 116. Teva Main Business Table 117. Teva Latest Developments Table 118. Pfizer Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 119. Pfizer Platinum based Cancer Drug Product Offered Table 120. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 121. Pfizer Main Business Table 122. Pfizer Latest Developments Table 123. Dr Reddy's Laboratories Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 124. Dr Reddy's Laboratories Platinum based Cancer Drug Product Offered Table 125. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 126. Dr Reddy's Laboratories Main Business Table 127. Dr Reddy's Laboratories Latest Developments Table 128. Mylan Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 129. Mylan Platinum based Cancer Drug Product Offered Table 130. Mylan Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 131. Mylan Main Business Table 132. Mylan Latest Developments Table 133. Sun Pharma Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 134. Sun Pharma Platinum based Cancer Drug Product Offered Table 135. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 136. Sun Pharma Main Business Table 137. Sun Pharma Latest Developments Table 138. Novartis Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 139. Novartis Platinum based Cancer Drug Product Offered Table 140. Novartis Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 141. Novartis Main Business Table 142. Novartis Latest Developments Table 143. Debiopharm Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 144. Debiopharm Platinum based Cancer Drug Product Offered Table 145. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 146. Debiopharm Main Business Table 147. Debiopharm Latest Developments Table 148. Accord Healthcare Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 149. Accord Healthcare Platinum based Cancer Drug Product Offered Table 150. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 151. Accord Healthcare Main Business Table 152. Accord Healthcare Latest Developments Table 153. SK Chemicals Basic Information, Platinum based Cancer Drug Manufacturing Base, Sales Area and Its Competitors Table 154. SK Chemicals Platinum based Cancer Drug Product Offered Table 155. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E) Table 156. SK Chemicals Main Business Table 157. SK Chemicals Latest Developments List of Figures Figure 1. Picture of Platinum based Cancer Drug Figure 2. Platinum based Cancer Drug Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Platinum based Cancer Drug Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Platinum based Cancer Drug Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Platinum based Cancer Drug Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Cisplatin Figure 10. Product Picture of Oxaliplatin Figure 11. Product Picture of Carboplatin Figure 12. Product Picture of Others Figure 13. Global Platinum based Cancer Drug Sales Market Share by Type in 2020 Figure 14. Global Platinum based Cancer Drug Revenue Market Share by Type (2016-2021) Figure 15. Platinum based Cancer Drug Consumed in Colorectal Cancer Figure 16. Global Platinum based Cancer Drug Market: Colorectal Cancer (2016-2021) & (K Units) Figure 17. Platinum based Cancer Drug Consumed in Ovarian Cancer Figure 18. Global Platinum based Cancer Drug Market: Ovarian Cancer (2016-2021) & (K Units) Figure 19. Platinum based Cancer Drug Consumed in Lung Cancer Figure 20. Global Platinum based Cancer Drug Market: Lung Cancer (2016-2021) & (K Units) Figure 21. Platinum based Cancer Drug Consumed in Others Figure 22. Global Platinum based Cancer Drug Market: Others (2016-2021) & (K Units) Figure 23. Global Platinum based Cancer Drug Sales Market Share by Application (2016-2021) Figure 24. Global Platinum based Cancer Drug Revenue Market Share by Application in 2020 Figure 25. Platinum based Cancer Drug Revenue Market by Company in 2020 ($ Million) Figure 26. Global Platinum based Cancer Drug Revenue Market Share by Company in 2020 Figure 27. Global Platinum based Cancer Drug Sales Market Share by Regions (2016-2021) Figure 28. Global Platinum based Cancer Drug Revenue Market Share by Region in 2020 Figure 29. Americas Platinum based Cancer Drug Sales 2016-2021 (K Units) Figure 30. Americas Platinum based Cancer Drug Revenue 2016-2021 ($ Millions) Figure 31. APAC Platinum based Cancer Drug Sales 2016-2021 (K Units) Figure 32. APAC Platinum based Cancer Drug Revenue 2016-2021 ($ Millions) Figure 33. Europe Platinum based Cancer Drug Sales 2016-2021 (K Units) Figure 34. Europe Platinum based Cancer Drug Revenue 2016-2021 ($ Millions) Figure 35. Middle East & Africa Platinum based Cancer Drug Sales 2016-2021 (K Units) Figure 36. Middle East & Africa Platinum based Cancer Drug Revenue 2016-2021 ($ Millions) Figure 37. Americas Platinum based Cancer Drug Sales Market Share by Country in 2020 Figure 38. Americas Platinum based Cancer Drug Revenue Market Share by Country in 2020 Figure 39. Americas Platinum based Cancer Drug Sales Market Share by Type in 2020 Figure 40. Americas Platinum based Cancer Drug Sales Market Share by Application in 2020 Figure 41. United States Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 42. Canada Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 43. Mexico Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 44. Brazil Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 45. APAC Platinum based Cancer Drug Sales Market Share by Region in 2020 Figure 46. APAC Platinum based Cancer Drug Revenue Market Share by Regions in 2020 Figure 47. APAC Platinum based Cancer Drug Sales Market Share by Type in 2020 Figure 48. APAC Platinum based Cancer Drug Sales Market Share by Application in 2020 Figure 49. China Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 50. Japan Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 51. Korea Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 52. Southeast Asia Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 53. India Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 54. Australia Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 55. Europe Platinum based Cancer Drug Sales Market Share by Country in 2020 Figure 56. Europe Platinum based Cancer Drug Revenue Market Share by Country in 2020 Figure 57. Europe Platinum based Cancer Drug Sales Market Share by Type in 2020 Figure 58. Europe Platinum based Cancer Drug Sales Market Share by Application in 2020 Figure 59. Germany Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 60. France Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 61. UK Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 62. Italy Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 63. Russia Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 64. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Country in 2020 Figure 65. Middle East & Africa Platinum based Cancer Drug Revenue Market Share by Country in 2020 Figure 66. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Type in 2020 Figure 67. Middle East & Africa Platinum based Cancer Drug Sales Market Share by Application in 2020 Figure 68. Egypt Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 69. South Africa Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 70. Israel Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 71. Turkey Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 72. GCC Country Platinum based Cancer Drug Revenue Growth 2016-2021 ($ Millions) Figure 73. Channels of Distribution Figure 74. Distributors Profiles |
| ※본 조사보고서 [세계의 백금 기반 암 치료제 시장예측 2021년-2026년] (코드 : LPI-2201K02153) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 백금 기반 암 치료제 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요. |